Commitments and Contingencies (Details) - USD ($) |
1 Months Ended | 6 Months Ended | ||||
|---|---|---|---|---|---|---|
Mar. 15, 2019 |
Apr. 10, 2019 |
Jun. 23, 2017 |
Jun. 30, 2019 |
Dec. 31, 2018 |
Jun. 07, 2017 |
|
| Commitments and Contingencies (Textual) | ||||||
| Underwriting commitments, description | The Company granted the underwriters a 45-day option to purchase up to 1,500,000 additional Units to cover over-allotments at the Initial Public Offering price, less the underwriting discounts and commissions. On June 23, 2017, the underwriters elected to exercise their over-allotment option to purchase 1,500,000 Units at a purchase price of $10.00 per Unit. | |||||
| Underwriting discount | $ 2,875,000 | |||||
| Deferred underwriting fees | $ 4,025,000 | $ 4,025,000 | ||||
| Purchased an aggregate, shares | 125,000 | |||||
| Purchased an aggregate, per unit | $ 10.10 | $ 10.00 | $ 0.0225 | |||
| Pecuniary interest, shares | 230,000 | |||||
| Related party transaction, description | The Company entered into the Term Sheet for the Transaction with CannBioRx. In connection with the Term Sheet, the CannBioRx Parties agreed to loan $400,000 to the Company to fund the Company's Operating Expenses and Extension Expenses. The loans are interest-free and can be pre-paid at any time without penalty, but are required to be paid back (subject to a customary waiver against the Company's Trust Account) upon the earlier of (i) the closing of the Transaction, (ii) the consummation by the Company of a transaction with a third party constituting the Company's initial Business Combination, or (iii) the liquidation of the Company if it does not consummate an initial Business Combination prior to its deadline to do so (a "Liquidation"). Promptly after signing the Term Sheet, the Company received the loan of $400,000 to fund the Operating Expenses. | |||||
| Convertible Promissory Note [Member] | ||||||
| Commitments and Contingencies (Textual) | ||||||
| Related party transaction, description | (i) the consummation of a Business Combination or (ii) the liquidation of the Company. Up to $1,000,000 of the loans under the Promissory Note may be converted, at the Sponsor's discretion, into units of the post-Business Combination entity at a price of $10.00 per unit. The units would be identical to the Private Units. | |||||
| Sponsor [Member] | Convertible Promissory Note [Member] | ||||||
| Commitments and Contingencies (Textual) | ||||||
| Related party transaction, description | In connection with the Term Sheet, a target shareholder (the "Target Shareholder") paid $650,000 to the Sponsor to purchase $650,000 of the obligations owed to the Sponsor under the Promissory Note (the "Sponsor Note"), but the Target Shareholder waived any rights under the assigned portion of the Sponsor Note to convert the obligations under the assigned portion of the Sponsor Note into units of the post-Business Combination entity. Pursuant to the Term Sheet, the Target Shareholder also agreed to provide equity financing for the Transaction to ensure that the Company has sufficient cash at the closing of the Transaction to meet its $5,000,001 net tangible assets test. | |||||
| IPO [Member] | ||||||
| Commitments and Contingencies (Textual) | ||||||
| Purchased an aggregate, shares | 1,500,000 | |||||
| Purchased an aggregate, per unit | $ 10.00 | $ 10.00 | ||||
| Founder Shares [Member] | ||||||
| Commitments and Contingencies (Textual) | ||||||
| Related party transaction, description | (i) one year after the completion of a Business Combination, and (ii) the date following the completion of a Business Combination on which the Company completes a liquidation, merger, share exchange or other similar transaction which results in all of the Company's stockholders having the right to exchange their shares of the Company's common stock for cash, securities or other property the ("Lock-Up Period"). Notwithstanding the foregoing, if the last sale price of the Company's common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after its initial Business Combination, then the lock-up will terminate. | |||||
| Founder Shares [Member] | IPO [Member] | ||||||
| Commitments and Contingencies (Textual) | ||||||
| Description of sponsor deposited in escrow | In connection with the Business Combination Agreement (as defined below), the Sponsor deposited in escrow with a third party escrow agent 1,406,250 of its Founder Shares that it acquired prior to the Company's Initial Public Offering (the "Escrowed Shares"). The Escrowed Shares will be transferred to the Target Shareholder, less any portion used for financing for the Transaction, upon the earlier of (i) the closing of the Transaction or (ii) a Liquidation; provided, that if the Company consummates its initial Business Combination with a third party other than CannBioRx or its affiliates, upon the consummation of such Business Combination, in addition to paying the loans described above, the Sponsor will transfer to the Target Shareholder a number of Escrowed Shares equal in value to three times the amount of the loans, with each Escrowed Share valued at the price paid to each public stockholder that redeems its shares in connection with such initial Business Combination. | |||||